Origene_Jan2021_ProperAntibodyDesignKeeps - 14
Coronavirus-Neutralizing Human Antibody Discovered
Vichie81 / Getty Images
47D11 neutralizes SARS-CoV and SARS-CoV-2
Wang, PhD, founder, Chairman & Chief Executive
through " a yet unknown mechanism " that is
Officer of HBM. " Much more work is needed to
different from receptor-binding interference. " Alter-
assess whether this antibody can protect or reduce
native mechanisms of coronavirus neutralization
the severity of disease in humans. We expect to
by RBD-targeting antibodies have been reported
advance development of the antibody with part-
including spike inactivation through antibody-in-
ners. We believe our technology can contribute to
duced destabilization of its prefusion structure,
addressing this most urgent public health need and
which may also apply for 47D11, " the team noted.
we are pursuing several other research avenues. " ●
" In conclusion, this is the first report of a
(human) monoclonal antibody that neutralizes
SARS-CoV-2, " they concluded. " This antibody will
be useful for development of antigen detection
tests and serological assays targeting SARS-CoV-2
... this antibody-either alone or in combination-offers the potential to prevent and/or treat
Need antibodies against SARSCOV2 or ACE2, including the
neutralizing antibodies?
Request
free samples
from OriGene
COVID-19, and possibly also other future emerging
diseases in humans caused by viruses from the
Sarbecovirus subgenus. "
" This is groundbreaking research, " said Jingsong
14 |
GENengnews.com
GO
https://www.origene.com/promotions/sars-cov-2-free-antibody-sample
http://www.GENengnews.com
Origene_Jan2021_ProperAntibodyDesignKeeps
Table of Contents for the Digital Edition of Origene_Jan2021_ProperAntibodyDesignKeeps
Contents
Origene_Jan2021_ProperAntibodyDesignKeeps - 1
Origene_Jan2021_ProperAntibodyDesignKeeps - 2
Origene_Jan2021_ProperAntibodyDesignKeeps - Contents
Origene_Jan2021_ProperAntibodyDesignKeeps - 4
Origene_Jan2021_ProperAntibodyDesignKeeps - 5
Origene_Jan2021_ProperAntibodyDesignKeeps - 6
Origene_Jan2021_ProperAntibodyDesignKeeps - 7
Origene_Jan2021_ProperAntibodyDesignKeeps - 8
Origene_Jan2021_ProperAntibodyDesignKeeps - 9
Origene_Jan2021_ProperAntibodyDesignKeeps - 10
Origene_Jan2021_ProperAntibodyDesignKeeps - 11
Origene_Jan2021_ProperAntibodyDesignKeeps - 12
Origene_Jan2021_ProperAntibodyDesignKeeps - 13
Origene_Jan2021_ProperAntibodyDesignKeeps - 14
Origene_Jan2021_ProperAntibodyDesignKeeps - 15
Origene_Jan2021_ProperAntibodyDesignKeeps - 16
Origene_Jan2021_ProperAntibodyDesignKeeps - 17
Origene_Jan2021_ProperAntibodyDesignKeeps - 18
Origene_Jan2021_ProperAntibodyDesignKeeps - 19
Origene_Jan2021_ProperAntibodyDesignKeeps - 20
Origene_Jan2021_ProperAntibodyDesignKeeps - 21
Origene_Jan2021_ProperAntibodyDesignKeeps - 22
Origene_Jan2021_ProperAntibodyDesignKeeps - 23
Origene_Jan2021_ProperAntibodyDesignKeeps - 24
Origene_Jan2021_ProperAntibodyDesignKeeps - 25
https://www.nxtbookmedia.com